NCT03741933View on ClinicalTrials.gov

Apremilast and Moderate to Severe Chronic Hand Dermatitis

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2019

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Chronic Hand Dermatitis
Interventions
DRUG

Apremilast 30mg

Apremilast 30 mg tablet

Trial Locations (1)

20037

George Washington University Department of Dermatology, Washington D.C.

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

George Washington University

OTHER